急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL) 急性髓细胞白血病(acute myeloblasticleukemia,AML)或称为急性非淋巴细胞白血病(ANLL) MICM分型方案:1999 年,世界卫生组织( WHO ) 在欧- 美淋巴组织肿瘤分类方案修订版(REAL)的基础上,将血液肿瘤相关疾病的临床特点与形态学(morphology)、免疫学(immunology)、细胞...
[8]Ting S, Mixue X, Lixia Z, et al. T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. ...
3.Rongshou Zheng, et al.Journal of the National Cancer Center,Volume 2, Issue 1,2022,Pages 1-9 4.Rosenthal J,Naqvi AS, Luo M, et al. Heterogeneity of surface CD19 and CD22 expression in B lymphoblastic leukemia[J]. ...
CD10(-) pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL). Blood. 2005;106:4054-6....
[10]Yi L, Hu Q, Zhou J, et al. Alternative splicing of Ikaros regulates the FUT4/Le(X)- alpha5beta1 integrin-FAK axis in acute lymphoblastic leukemia[J]. Biochem Biophys Res Commun, 2019,510 (1):128-134. 性侵犯 淋巴瘤
迄今为止,已经有8种CART细胞上市,用来治疗复发/难治性(refractory/recurrence,R/R)非霍奇金淋巴瘤(non-Hodgkin lymphoma,NHL)、急性B淋巴细胞白血病(acute B lymphoblastic leukemia,B-ALL)和多发性骨髓瘤[3-5]。但对于细胞治疗过程中...
B-cell Acute Lymphoblastic Leukemia-1Cells;细胞背景资料:详见相关文献介绍;细胞传代方法:1:2传代;细胞生长特性:悬浮生长;细胞形态特性:淋巴母Cells;相关细胞有:SMMC7721Cells、NCI-HUT-460Cells、LSC-1细胞 A.704Cells;细胞背景资料:详见相关文献介绍;细胞传代方法:1:3—1:4传代,每周换液2-3次;细胞生长特性:...
(Ph-Like) ABL-class B-Cell acute lymphoblastic leukemia (B-ALL). Blinatumomab is a bispecific antibody that binds to two different proteins-one on the surface of cancer cells and one on the surface of cells in the immune system. An antibody is a protein made by the immune system to ...
HCT-8/V细胞类似产品::DR2R 1610细胞、B-cell Acute Lymphoblastic Leukemia-1细胞、TCCSUP细胞 8305C_1细胞类似产品::NCI-H2087细胞、P-815细胞、H345细胞 BT-20细胞类似产品::Ramos (RA 1)细胞、H-1694细胞、MC-4细胞 NCI-H1105细胞类似产品::NCI-H1694细胞、RKO-E6细胞、Sup T-1细胞 ...
Abstract 964丨CD7 CAR-T-cell Therapy in Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia-a Retrospective Study 研究目的 该研究通过结合两项临床试验(I期试验和II期试验)的结果进行了回顾性分析,旨在进一步明确接受CD7 CAR-T细胞疗法的复发/难治性急性T淋巴细胞白血病(R/R T-ALL)患者的生存预后因素...